Guided Therapeutics Inc (GTHP) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
5835 PEACHTREE CORNERS EAST PEACHTREE CORNERS, GA 30092 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,313 | 643 | 182 | 899 | |||||
| Cash and cash equivalent | 2,313 | 643 | 182 | 899 | |||||
| Receivables | 3 | 7 | 6 | 172 | |||||
| Inventory, net of allowances, customer advances and progress billings | 633 | 632 | 548 | 571 | 605 | 48 | |||
| Inventory | 633 | 632 | 548 | 571 | 605 | 48 | |||
| Other current assets | 173 | 163 | 137 | 377 | 85 | 70 | |||
| Other undisclosed current assets | 388 | 591 | (126) | 24 | 13 | ||||
| Total current assets: | 1,197 | 1,393 | 3,004 | 1,637 | 896 | 1,030 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 141 | 227 | 303 | 372 | 453 | 132 | |||
| Property, plant and equipment | 23 | 32 | 42 | 14 | 1 | ||||
| Other noncurrent assets | 17 | 17 | 17 | 17 | |||||
| Other undisclosed noncurrent assets | 18 | ||||||||
| Total noncurrent assets: | 181 | 276 | 362 | 403 | 454 | 150 | |||
| TOTAL ASSETS: | 1,378 | 1,669 | 3,366 | 2,040 | 1,350 | 1,180 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 3,105 | 2,961 | 3,433 | 4,740 | 7,133 | 7,375 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 610 | 1,719 | 120 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,123 | ||||
| Accounts payable | 2,094 | 1,991 | 2,186 | 2,362 | 2,419 | 2,897 | |||
| Accrued liabilities | 1,011 | 970 | 1,247 | 1,768 | 2,995 | 3,235 | |||
| Deferred revenue | 849 | 424 | 509 | 337 | 42 | ||||
| Debt | 167 | 118 | 132 | 136 | 73 | 1,335 | |||
| Derivative instruments and hedges, liabilities | 118 | ||||||||
| Due to related parties | ✕ | ✕ | ✕ | 40 | 87 | 116 | 136 | ||
| Other undisclosed current liabilities | 1,916 | 1,306 | 755 | 394 | 1,598 | 3,564 | |||
| Total current liabilities: | 6,155 | 4,809 | 4,869 | 5,694 | 8,962 | 12,410 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 61 | 1,046 | 325 | 415 | 44 | ||||
| Long-term debt, excluding current maturities | 61 | 1,046 | 23 | 15 | |||||
| Liabilities, other than long-term debt | 49 | 155 | 334 | 624 | 625 | 569 | |||
| Due to related parties | ✕ | ✕ | ✕ | 83 | 592 | 600 | 569 | ||
| Operating lease, liability | 49 | 155 | 246 | 325 | 392 | 29 | |||
| Derivative instruments and hedges, liabilities | 5 | 32 | 25 | ||||||
| Other undisclosed noncurrent liabilities | 2 | 511 | 842 | 2,203 | 5,092 | ||||
| Total noncurrent liabilities: | 112 | 666 | 1,380 | 1,791 | 3,243 | 5,705 | |||
| Total liabilities: | 6,267 | 5,475 | 6,249 | 7,485 | 12,205 | 18,115 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (4,889) | (3,806) | (2,883) | (5,445) | (10,855) | (16,935) | |||
| Common stock | 3,452 | 3,441 | 3,437 | 3,403 | 3,403 | 3,394 | |||
| Treasury stock, value | (132) | (132) | (132) | (132) | (132) | (132) | |||
| Common stock, value, subscriptions | 351 | ||||||||
| Additional paid in capital | 142,501 | 140,983 | 138,090 | 126,800 | 123,109 | 118,552 | |||
| Accumulated deficit | (153,709) | (151,118) | (147,359) | (142,387) | (139,956) | (139,555) | |||
| Other undisclosed equity, attributable to parent | 2,999 | 3,020 | 3,081 | 6,520 | 2,721 | 806 | |||
| Other undisclosed equity | (11) | ||||||||
| Total equity: | (4,900) | (3,806) | (2,883) | (5,445) | (10,855) | (16,935) | |||
| Other undisclosed liabilities and equity | 11 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 1,378 | 1,669 | 3,366 | 2,040 | 1,350 | 1,180 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 7 | 98 | 13 | 81 | 102 | 36 | ||
| Net investment income | 3 | 6 | ||||||
| Other income | 16 | 507 | 271 | 48 | ||||
| Cost of revenue | (5) | (62) | (81) | (70) | ||||
| Cost of product and service sold | (5) | (62) | (81) | |||||
| Other undisclosed gross profit | (61) | 41 | ||||||
| Gross profit: | 2 | 36 | (68) | 20 | 143 | (34) | ||
| Operating expenses | (2,110) | (3,493) | (3,265) | (2,382) | (1,195) | (903) | ||
| Operating loss: | (2,108) | (3,457) | (3,333) | (2,362) | (1,052) | (937) | ||
| Nonoperating income (expense) | (309) | (32) | (1,008) | 292 | 773 | (984) | ||
| Other nonoperating income (expense) | 18 | 39 | (1,008) | 292 | 773 | (984) | ||
| Interest and debt expense | (278) | (655) | 578 | (296) | (1,412) | |||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 278 | 655 | (578) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (2,417) | (3,489) | (4,341) | (2,070) | (575) | (3,333) | ||
| Other undisclosed income from continuing operations before income taxes | 296 | 1,412 | ||||||
| Loss from continuing operations: | (2,417) | (3,489) | (4,341) | (2,070) | (279) | (1,921) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (2,070) | (279) | (1,921) | |
| Other undisclosed net loss | ||||||||
| Net loss: | (2,417) | (3,489) | (4,341) | (2,070) | (279) | (1,921) | ||
| Other undisclosed net income attributable to parent | ||||||||
| Net loss attributable to parent: | (2,417) | (3,489) | (4,341) | (2,070) | (279) | (1,921) | ||
| Preferred stock dividends and other adjustments | (122) | |||||||
| Other undisclosed net loss available to common stockholders, basic | (174) | (270) | (631) | (361) | ||||
| Net loss available to common stockholders, diluted: | (2,591) | (3,759) | (4,972) | (2,431) | (401) | (1,921) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,417) | (3,489) | (4,341) | (2,070) | (279) | (1,921) | ||
| Comprehensive loss, net of tax, attributable to parent: | (2,417) | (3,489) | (4,341) | (2,070) | (279) | (1,921) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.